Reuters: Microsoft (MSFT) is putting more R&D in India.
Reuters: CIT (CIT) confirmed that it rasied $3 billion.
Reuters: Bernanke said Fed can control inflation.
Reuters: California lawmakers agreed to a state budget.
Reuters: Small business groups are seeking help to keep companies afloat.
Reuters: TI (TXN) profits and outlook beat expectations.
Reuters: Obama said Wall St. banks have failed to show remorse for their losses.
Reuters: Investors are looking for more earnings surprises.
Reuters: Expectations are high for Apple’s (AAPL) earnings.
Reuters: Halliburton (HAL) profits fell but beat expectations.
WSJ: Many Swiss banks are declining US deposits in the wake of problems with UBS (UBS).
WSJ: Deutsche Bank (DB) fired two executives over whether they spied on other managers.
WSJ: CIT’s fate still rests with regulators.
WSJ: Executives and other well-compensated employees now receive one-third of all pay in the US.
WSJ: Yahoo! (YHOO) is expected to launch its homepage as early as today.
WSJ: The Porsche deal with VW is still facing problems.
WSJ: Barnes & Noble (BKS) will challenge the Amazon (AMZN) Kindle.
WSJ: Sony (SNE) has signed a deal with Redbox to supply its films in the distributor’s kiosks.
WSJ: TD Ameritrade (AMTD) will return hundreds of millions of dollars to customers after settling ARS charges.
WSJ: Wynn (WYNN) will have an IPO of its Macau assets.
WSJ: The New York Times (NYT) Boston Globe property will cut wages and benefits.
WSJ: Morgan Stanley (MS) will be the primary adviser on spin-outs of AIG (AIG) assets.
WSJ: LG is taking market share from rival cell phone companies.
WSJ: Toyota (TM) said it lost touch with the US market.
WSJ: GM has three final bids for Opel.
WSJ: UnitedHealth (UNH) will buy part of Health Net.
NYT: Policy markets are trying to revive US manufacturing.
NYT: Barnes and Noble plans to make itself the world’s largest online bookstore.
NYT: Congress may back off from large taxes for the rich to fund health care changes.
FT: Swine flu vaccines are likely to make GlaxoSmithKline (GSK), Roche, and Sanofi-Aventis billions of dollars.
Bloomberg: Summers challenged banks on foreclosures.
Douglas A. McIntyre
